CLINICAL_TRIALS ClinicalTrials.gov record update

Study in Healthy Children of GSK Biologicals' DTPa-IPV/Hib-MenC-TT Vaccine, GSK2197870A, Co-administered With Prevenar™ as a Three-dose Primary Vaccination Course in Infancy Followed by a Booster Dose of Menitorix™ at 12 Months of Age

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00871338
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:54.772136+00:00
Published At: 2014-07-28T00:00:00+00:00
Record Updated At: 2018-06-06
Results Posted At: 2014-07-28
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Neisseria Meningitidis", "Haemophilus Influenzae Type b"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-06-06"
protocolSection.identificationModule.nctId: "NCT00871338"
protocolSection.identificationModule.officialTitle: "Study in Healthy Children of GSK Biologicals\u0027 DTPa-IPV/Hib-MenC-TT Vaccine, GSK2197870A, Co-administered With Prevenar\u2122 as a Three-dose Primary Vaccination Course in Infancy Followed by a Booster Dose of Menitorix\u2122 at 12 Months of Age"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2014-07-28"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.